Makers of copycat versions of Novo Nordisk's (NVO) weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing ...

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

Pesquisadores do Instituto de Virologia de Wuhan na China disseram que descobriram um novo coronavírus em morcegos que entra ...

The Justice Department has launched an investigation into the company's Medicare billing practices, [The Wall Street Journal reported]( ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

Dutch tank storage company Vopak reported 2024 core earnings above its guidance range on Wednesday, driven by strong demand ...